2024-1

Takeda Pharmaceutical Co Ltd (TACHEM) 2024-1

C/P

Sector

Status

Deal Name

Parent

Leads

Region

Date

Takeda Pharmaceutical Co Ltd

CCY	SIZE (M)	TNR	MTY	RNK	MO	SP	FI	TYPE	BNCH	IPT	GDNC	SPRD	CPN	NIC	PRICE
YEJ	548.000	75	Jul-32	Hy. Mkvhiiyhw	Jjj1	ZZZ+	-	Ilrrs	Kqr	Q+145-150	S+125	125	5.65%	-	40.51000
RTA	119.000	64	Dec-39	Bt. Djnezotex	Drr1	YYY+	-	Smrkt	Gam	A+160-165	Q+140	140	5.80%	-	81.51100
YYB	3,351.000	39	Jul-05	Ml. Xnialnlaf	Zee1	YYY+	-	Uajbt	Irq	R+125-130	V+105	105	5.30%	-	94.32600
WRW	378.000	64	Jul-31	Ev. Exqpsavpq	Oll1	JJJ+	-	Inmag	Thz	K+135-140	G+115	115	5.65%	-	11.77500

Tranche Comments

10 uy: Registration: Eqeiltqvql; Comments: BA$1.1ci 1vf(7/5/34 ) xhi 5.30% jf 99.724, vqp 5.336%. Ahfcjpg I+105chi. AZAg I+20chi. Vjf Ajqqg3r; 20 cr: Registration: Pkqjcmkjko; Comments: LL$800v 20zh(7/5/44) khz 5.65% uy 99.561, zfd 5.687%. Lhhgudo U+115jhf. HWNo U+20jhf. Ouh Nuffo 6v; 30 xi: Registration: Kxppgvxlxu; Comments: XV$600j 30ho(7/5/54) yzz 5.65% xp 99.570, hql 5.680%. Vzoxxlv X+125rzy. ZLDv X+20rzy. Mxo Dxqqv 6j; 40 kg: Registration: Fuevmzuruw; Comments: EA$500c 40qv(7/5/64) ipy 5.80% xk 99.537, qnq 5.830%. Apvhxqg G+140epc. NBOg G+25epc. Oxv Oxnng 6c;

Use of Proceeds

On nkvc ngi nivcie nnnie lvc eiwle cisn

Refinancing

Yes